James L.M. Ferrara

29.4k total citations · 5 hit papers
270 papers, 18.6k citations indexed

About

James L.M. Ferrara is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, James L.M. Ferrara has authored 270 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Hematology, 149 papers in Immunology and 39 papers in Oncology. Recurrent topics in James L.M. Ferrara's work include Hematopoietic Stem Cell Transplantation (200 papers), Immune Cell Function and Interaction (74 papers) and T-cell and B-cell Immunology (74 papers). James L.M. Ferrara is often cited by papers focused on Hematopoietic Stem Cell Transplantation (200 papers), Immune Cell Function and Interaction (74 papers) and T-cell and B-cell Immunology (74 papers). James L.M. Ferrara collaborates with scholars based in United States, Germany and Japan. James L.M. Ferrara's co-authors include Pavan Reddy, John E. Levine, Geoffrey R. Hill, Kenneth R. Cooke, Ernst Holler, Takanori Teshima, Chen Liu, Werner Krenger, Luying Pan and Yani S. Brinson and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

James L.M. Ferrara

263 papers receiving 18.3k citations

Hit Papers

Graft-versus-host disease 1997 2026 2006 2016 2009 1997 2000 2014 2018 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James L.M. Ferrara United States 77 11.9k 10.1k 3.4k 2.7k 1.7k 270 18.6k
Ernst Holler Germany 63 9.3k 0.8× 6.6k 0.7× 3.1k 0.9× 3.1k 1.1× 1.8k 1.0× 370 16.6k
Edwin P. Alyea United States 72 10.6k 0.9× 6.8k 0.7× 4.1k 1.2× 1.5k 0.6× 2.4k 1.4× 293 15.7k
Vincent T. Ho United States 65 10.4k 0.9× 5.8k 0.6× 3.4k 1.0× 1.2k 0.4× 2.1k 1.2× 323 14.9k
Donna Przepiorka United States 59 12.0k 1.0× 5.6k 0.6× 5.5k 1.6× 1.8k 0.7× 3.0k 1.8× 197 18.2k
Corey Cutler United States 73 13.1k 1.1× 6.8k 0.7× 4.0k 1.2× 1.6k 0.6× 3.2k 1.9× 449 18.2k
Jeff Szer Australia 58 8.4k 0.7× 4.8k 0.5× 3.5k 1.0× 1.5k 0.5× 3.2k 1.8× 385 15.3k
Robert J. Soiffer United States 89 15.0k 1.3× 10.6k 1.1× 7.1k 2.1× 2.7k 1.0× 3.7k 2.1× 506 25.4k
Vanderson Rocha France 62 10.9k 0.9× 4.0k 0.4× 3.2k 0.9× 1.7k 0.6× 3.6k 2.1× 445 14.8k
Richard J. Jones United States 66 7.8k 0.7× 3.8k 0.4× 4.3k 1.3× 3.3k 1.2× 2.4k 1.4× 333 14.4k
Aloïs Gratwohl Switzerland 80 17.1k 1.4× 5.7k 0.6× 4.7k 1.4× 2.8k 1.0× 4.8k 2.8× 515 23.8k

Countries citing papers authored by James L.M. Ferrara

Since Specialization
Citations

This map shows the geographic impact of James L.M. Ferrara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L.M. Ferrara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L.M. Ferrara more than expected).

Fields of papers citing papers by James L.M. Ferrara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L.M. Ferrara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L.M. Ferrara. The network helps show where James L.M. Ferrara may publish in the future.

Co-authorship network of co-authors of James L.M. Ferrara

This figure shows the co-authorship network connecting the top 25 collaborators of James L.M. Ferrara. A scholar is included among the top collaborators of James L.M. Ferrara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L.M. Ferrara. James L.M. Ferrara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoli, Aaron Etra, Jean‐Frédéric Colombel, et al.. (2025). Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease. Gut. 74(6). 894–905. 1 indexed citations
2.
Utrero‐Rico, Alberto, Tatiana Goncharov, Joshua D. Webster, et al.. (2023). Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects. Science Translational Medicine. 15(727). eadf8366–eadf8366. 8 indexed citations
3.
Héja, Dávid, Dongchang Zhao, Arun Čumpelik, et al.. (2022). Mannan-Binding Lectin Promotes Murine Graft-versus-Host Disease by Amplifying Lipopolysaccharide-Initiated Inflammation. Transplantation and Cellular Therapy. 28(8). 472.e1–472.e11.
4.
Groth, Christoph, Manita Bremmers, Frank Preijers, et al.. (2017). A Phase I/II Study on the Anti-CD3/CD7 Immunotoxin Combination (T-GuardTM) for the Treatment of Steroid-Refractory Acute Gvhd. Blood. 130. 513–513. 1 indexed citations
5.
Tkachev, Victor, Anthony W. Opipari, Ling-Yang Hao, et al.. (2015). Programmed Death-1 Controls T Cell Survival by Regulating Oxidative Metabolism. The Journal of Immunology. 194(12). 5789–5800. 101 indexed citations
6.
Holler, Ernst, Karin Schmid‐Zalaudek, Christian Hundsrucker, et al.. (2014). Metagenomic analysis of the stool microbiome in patients receiving allogeneic SCT: Loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal GvHD. University of Regensburg Publication Server (University of Regensburg). 4 indexed citations
7.
Levine, John E., Brent R. Logan, Juan Wu, et al.. (2012). Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. Blood. 119(16). 3854–3860. 133 indexed citations
8.
Kato, Koji, Shuaiying Cui, Rork Kuick, et al.. (2010). Identification of Stem Cell Transcriptional Programs Normally Expressed in Embryonic and Neural Stem Cells in Alloreactive CD8+ T Cells Mediating Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 16(6). 751–771. 18 indexed citations
9.
Salmasian, Hojjat, Mersedeh Rohanizadegan, Setareh Sadat Banihosseini, et al.. (2010). Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. Cochrane Database of Systematic Reviews. 2010(2). CD005565–CD005565. 22 indexed citations
10.
Paczesny, Sophie, Oleg I. Krijanovski, Thomas Braun, et al.. (2008). A biomarker panel for acute graft-versus-host disease. Blood. 113(2). 273–278. 290 indexed citations
11.
MacDonald, Kelli P. A., Vanessa Rowe, Andrew D. Clouston, et al.. (2005). Cytokine Expanded Myeloid Precursors Function as Regulatory Antigen-Presenting Cells and Promote Tolerance through IL-10-Producing Regulatory T Cells. The Journal of Immunology. 174(4). 1841–1850. 116 indexed citations
12.
Reddy, Pavan, Yoshinobu Maeda, Kevin B. Hotary, et al.. (2004). Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proceedings of the National Academy of Sciences. 101(11). 3921–3926. 213 indexed citations
13.
Duffner, Ulrich, Yoshinobu Maeda, Kenneth R. Cooke, et al.. (2004). Host Dendritic Cells Alone Are Sufficient to Initiate Acute Graft-versus-Host Disease. The Journal of Immunology. 172(12). 7393–7398. 193 indexed citations
14.
Ordemann, Rainer, Raymond J. Hutchinson, Jeffrey Friedman, et al.. (2002). Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. Journal of Clinical Investigation. 109(9). 1249–1256. 71 indexed citations
15.
Reddy, Vijay, Geoffrey R. Hill, Luying Pan, et al.. (2000). G-CSF MODULATES CYTOKINE PROFILE OF DENDRITIC CELLS AND DECREASES ACUTE GRAFT-VERSUS-HOST DISEASE THROUGH EFFECTS ON THE DONOR RATHER THAN THE RECIPIENT. Transplantation. 69(4). 691–693. 73 indexed citations
16.
Ferrara, James L.M.. (2000). Pathogenesis of Acute Graft-Versus-Host Disease: Cytokines and Cellular Effectors. Journal of Hematotherapy & Stem Cell Research. 9(3). 299–306. 134 indexed citations
17.
Hill, Geoffrey R., Takanori Teshima, Vivienne I. Rebel, et al.. (2000). The p55 TNF-α Receptor Plays a Critical Role in T Cell Alloreactivity. The Journal of Immunology. 164(2). 656–663. 104 indexed citations
18.
Schwaighofer, H, Holger Hebart, M. Herold, et al.. (1997). ENDOGENOUS INTERLEUKIN 1 RECEPTOR ANTAGONIST DURING HUMAN BONE MARROW TRANSPLANTATION. Transplantation. 63(1). 52–56. 13 indexed citations
19.
Krenger, Werner & James L.M. Ferrara. (1996). Graft-versus-host disease and the Th1/Th2 paradigm. Immunologic Research. 15(1). 50–73. 123 indexed citations
20.
Down, Julian D., Peter Mauch, Michael J. Warhol, S Neben, & James L.M. Ferrara. (1992). THE EFFECT OF DONOR T LYMPHOCYTES AND TOTAL-BODY IRRADIATION ON HEMOPOIETIC ENGRAFTMENT AND PULMONARY TOXICITY FOLLOWING EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION. Transplantation. 54(5). 802–808. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026